A New Jersey jury found Merck liable Tuesday of misrepresenting Vioxx to federal regulators and ordered the drugmaker to pay $9 million in punitive damages to a man who suffered a heart attack after taking the painkiller.

A jury came back with a decision on Tuesday to award $9 million in punitive damages to a New Jersey man who blamed Merck and Co. Inc.'s Vioxx painkiller for his heart attack. Millions of users of the drug in the U.S. paid special...

A New Jersey jury found Merck liable Tuesday of misrepresenting Vioxx to federal regulators and ordered the drug giant to pay $9 million in punitive damages to a man who suffered a heart attack after taking the painkiller.

A New Jersey jury found Merck liable Tuesday of misrepresenting Vioxx to federal regulators and ordered the drug giant to pay $9 million in punitive damages to a man who suffered a heart attack after taking the painkiller.

Drug firm Merck is told to pay a US man $9m in damages after its painkiller Vioxx was found to have led to his heart attack.

Reuters - A jury on Tuesday awarded $9 million in punitive damages to a New Jersey man who blamed Merck & Co. Inc.'s Vioxx painkiller for his heart attack.

Reuters - Jurors deciding whether to award punitive damages to a New Jersey man who said Merck & Co. Inc.'s Vioxx painkiller caused his heart attack reached a decision on Tuesday.

AP - A jury has awarded $9 million in punitive damages to a man who blamed his heart attack on Vioxx, finding that manufacturer Merck & Co. failed to warn about the risks of its arthritis drug and misrepresented the risks to physicians.

Reuters - Jurors deciding whether to award punitive damages to a New Jersey man who blamed his heart attack on Merck & Co. Inc.'s Vioxx painkiller adjourned without reaching a verdict on Monday after six hours of deliberations.

Reuters - Jurors began deliberating on Monday whether to award punitive damages to a New Jersey man who suffered a heart attack while taking Merck & Co.'s drug Vioxx.

A judge rejected a Merck and Co. lawyer's request to stop a jury hearing on possible punitive damages for a former Vioxx user who had a heart attack after using the painkiller for four years. With jurors out of the courtroom on...

Reuters - Merck & Co. Inc. asked a judge on Friday to dismiss the punitive phase of this Vioxx liability case, arguing that the plaintiff's attorneys had not presented evidence that showed the drugmaker hid data on its painkiller from regulators, but the motion was denied.

AFP - A jury has ordered pharma giant Merck to pay 4.5 million dollars to a man claiming that the pain medication Vioxx had caused his heart attack, the Wall Street Journal reported Wednesday.

AP - A jury found Merck & Co. liable on Wednesday for one of two former Vioxx users' heart attacks in a split verdict that awarded $4.5 million in damages to one of the plaintiffs.

Reuters - A jury on Wednesday found Merck & Co. failed to warn Vioxx users of the drug's heart risks and ordered it to pay a 77-year-old plaintiff at least $4.5 million in a decision that raises questions about the company's future defense of thousands of lawsuits filed over the medicine.

In a split verdict, Merck and Co. is ordered to pay $4.5 million to one plaintiff, while the other is awarded just $45. A jury in New Jersey found that Merck failed to warn both men that using the painkiller could lead to heart...

AP - A state jury found Merck & Co. liable on Wednesday for one of two former Vioxx users' heart attacks and ordered he receive $4.5 million in damages in a closely-watched trial involving two New Jersey men.

Reuters - Jurors deliberating in the latest Vioxx product liability trial asked to see a sample pack of the pain-killing drug, but were not permitted to do so because such a pack had not been formally admitted into evidence, attorney Jerry Kristal said on Wednesday.

Reuters - Merck & Co. Inc. on Tuesday said it expects its first-quarter results to top its prior view, boosted by strong sales of its Zocor cholesterol drug.

Reuters - ImClone Systems Inc. said on Tuesday that an arbitrator has decided in its favor in a dispute with German drugs and chemicals maker Merck KGaA over rights to develop and commercialize an antibody used in cancer treatment.